DL-Tartaric acid

Details

Top
Internal ID 22579e8a-e958-417f-a440-1b9531128f26
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Sugar acids and derivatives
IUPAC Name 2,3-dihydroxybutanedioic acid
SMILES (Canonical) C(C(C(=O)O)O)(C(=O)O)O
SMILES (Isomeric) C(C(C(=O)O)O)(C(=O)O)O
InChI InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)
InChI Key FEWJPZIEWOKRBE-UHFFFAOYSA-N
Popularity 11,859 references in papers

Physical and Chemical Properties

Top
Molecular Formula C4H6O6
Molecular Weight 150.09 g/mol
Exact Mass 150.01643791 g/mol
Topological Polar Surface Area (TPSA) 115.00 Ų
XlogP -1.90
Atomic LogP (AlogP) -2.12
H-Bond Acceptor 4
H-Bond Donor 4
Rotatable Bonds 3

Synonyms

Top
DL-Tartaric acid
tartaric acid
2,3-Dihydroxybutanedioic acid
526-83-0
133-37-9
Racemic acid
Uvic acid
Traubensaure
Racemic tartaric acid
DL-Tartrate
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of DL-Tartaric acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5220 52.20%
Caco-2 - 0.9768 97.68%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.5143 51.43%
Subcellular localzation Mitochondria 0.7202 72.02%
OATP2B1 inhibitior - 0.8610 86.10%
OATP1B1 inhibitior + 0.9748 97.48%
OATP1B3 inhibitior + 0.9661 96.61%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9812 98.12%
P-glycoprotein inhibitior - 0.9755 97.55%
P-glycoprotein substrate - 0.9977 99.77%
CYP3A4 substrate - 0.8263 82.63%
CYP2C9 substrate + 0.5973 59.73%
CYP2D6 substrate - 0.8595 85.95%
CYP3A4 inhibition - 0.8884 88.84%
CYP2C9 inhibition - 0.9071 90.71%
CYP2C19 inhibition - 0.9695 96.95%
CYP2D6 inhibition - 0.9544 95.44%
CYP1A2 inhibition - 0.9357 93.57%
CYP2C8 inhibition - 0.9969 99.69%
CYP inhibitory promiscuity - 0.9877 98.77%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.6296 62.96%
Carcinogenicity (trinary) Non-required 0.7788 77.88%
Eye corrosion - 0.9886 98.86%
Eye irritation + 0.6353 63.53%
Skin irritation + 0.5301 53.01%
Skin corrosion - 0.9639 96.39%
Ames mutagenesis - 0.9500 95.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8485 84.85%
Micronuclear - 0.7800 78.00%
Hepatotoxicity + 0.6175 61.75%
skin sensitisation - 0.9377 93.77%
Respiratory toxicity - 0.9111 91.11%
Reproductive toxicity - 0.8333 83.33%
Mitochondrial toxicity - 0.9500 95.00%
Nephrotoxicity + 0.4609 46.09%
Acute Oral Toxicity (c) III 0.8267 82.67%
Estrogen receptor binding - 0.8274 82.74%
Androgen receptor binding - 0.8527 85.27%
Thyroid receptor binding - 0.7707 77.07%
Glucocorticoid receptor binding - 0.7731 77.31%
Aromatase binding - 0.8169 81.69%
PPAR gamma - 0.7357 73.57%
Honey bee toxicity - 0.9185 91.85%
Biodegradation + 0.7250 72.50%
Crustacea aquatic toxicity - 0.9700 97.00%
Fish aquatic toxicity - 0.6079 60.79%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 82.77% 96.09%

Cross-Links

Top
PubChem 875
LOTUS LTS0061981
wikiData Q194322